Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Comment by retiredcopon Jul 14, 2023 10:48am
134 Views
Post# 35541145

RE:RE:New Press Release - ProMIS Announces Completion of Continuance

RE:RE:New Press Release - ProMIS Announces Completion of ContinuanceI would think that it means they are remaining as a registered company for financial and company reporting and they have to file taxes each year.  I personally think it's wise to stay as a Canadian company, and I am not sure about this , but I think they have amassed 10s of millions $ in capital losses which should still be on their tax files.  If it works like it would for us, when they suddenly start bringing in money or showing gains, they can offset those gains with all the losses they have on record.  Maybe someone out there can verify what I think.  I remember before they became ProMIS, the ceo indicated that they could be bought out becuae they had accumulated such a large amount of capital loss and there are companies out there that will buy a failing company so they can get access to losses for tax purposes.   Maybe some of the long time investors can remember the numbers from before 2014 
<< Previous
Bullboard Posts
Next >>